Elucidating the precise pharmacological mechanism of action (MOA) of naturally happening compounds might be challenging. Whilst Tarselli et al. (60) made the very first de novo artificial pathway to conolidine and showcased that this naturally happening compound properly suppresses responses to both chemically induced and inflammation-derived pain,… Read More